Artificial Intelligence in Pharmaceutical Industry Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Artificial Intelligence (AI) in Pharmaceutical Market Report is Segmented by Technology (Machine Learning and Other Technologies), Type (Software and Services), Application (Drug Discovery, Clinical Trial, Laboratory Automation, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Size and Forecast Values are Provided in Terms of (USD) for all the Above Segments.

Artificial Intelligence in Pharmaceutical Industry Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Artificial Intelligence (AI) In Pharmaceutical Indusrty Overview

The artificial intelligence in the pharmaceutical market is fragmented in nature. In the current pharmaceutical market, the use of artificial intelligence (AI) has become increasingly prevalent, with a number of global players focusing on differentiating themselves in a highly competitive space. Also, there has been a recent influx of new market entrants rapidly gaining traction. Overall, competitive rivalry within the industry is expected to remain high during the forecast period.

Some of the major players in the AI pharmaceutical market include Alphabet Inc. (Isomorphic Labs), Atomwise Inc., BenevolentAI, BioSymetrics, Cloud Pharmaceuticals Inc., Deep Genomics, Deargen Inc., Euretos, Exscientia, Insilico Medicine, Cyclica Inc., and InveniAI LLC.

Artificial Intelligence (AI) In Pharmaceutical Market Leaders

  1. Deep Genomics

  2. Euretos

  3. Exscientia

  4. Insilico Medicine

  5. Alphabet Inc. (Isomorphic Labs)

  6. *Disclaimer: Major Players sorted in no particular order
Artificial Intelligence (AI) In Pharmaceutical Market Concentration

AI in Pharma Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?